Results 201 to 210 of about 376,929 (300)

Lithium Borate/Boric Acid Optimized Multifunctional Binder Facilitates Silicon Anodes With Enhanced Initial Coulombic Efficiency, Structural Strength, and Cycling Stability

open access: yesBattery Energy, Volume 4, Issue 2, March 2025.
This research introduces a novel organic‐inorganic binder: sodium alginate‐lithium borate‐boric acid (Alg‐LBO‐BA), whose three‐dimensional network effectively buffers the volumetric changes of Si, maintaining overall stability. Additionally, LBO serves as a prelithiation agent, compensating for irreversible lithium consumption during SEI formation ...
Xiang Wang   +12 more
wiley   +1 more source

Allelopathy as a Strategy for Biological Invasion: Calotropis procera and Its Impact on Plant Succession

open access: yesChemistry &Biodiversity, EarlyView.
Stages of the study on the allelopathic potential of Calotropis procera (Aiton) W. T. Aiton. The image shows the collection of plant material, the decomposition of organic matter, the identification of bioactive compounds, and the effects on the germination of Handroanthus impetiginosus (Mart. ex DC.) Mattos.
Bruno Melo de Alcântara   +7 more
wiley   +1 more source

Purification, Fluorescent Labeling, and Detyrosination of Mammalian Cell Tubulin for Biochemical Assays

open access: yesCytoskeleton, EarlyView.
ABSTRACT Microtubules play essential roles in numerous cellular processes. All microtubules are built from the protein tubulin, yet individual microtubules can differ spatially and temporally due to their tubulin isotype composition and post‐translational modifications (PTMs).
Ezekiel C. Thomas   +5 more
wiley   +1 more source

Human disturbance thresholds determine the ecological role of an apex predator. [PDF]

open access: yesSci Rep
Preiss-Bloom S   +4 more
europepmc   +1 more source

Foundational Principles for the Quantitative Translation of T‐Cell Therapeutics for Hematologic Malignancies and Immunology

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
T‐cell engaging antibodies (TCEs) and chimeric antigen receptor (CAR) T cells (CAR‐T cells) are among precision medicine therapies that have revolutionized the treatment of hematologic cancers. Their success in oncology has piqued interest in translating this promise into additional indications, such as autoimmune disorders.
Peter Ashcroft   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy